Apr 17, 2024
Apr 17, 2024
Autism Tsunami: The Cost of the Aging Autism Population
On ‘Defender In-Depth’ this week:
- How Big Pharma and private equity funds see autism treatment as a ‘market opportunity’
- Efforts being undertaken by parents of kids with neurological disorders
- Autism’s future costs
- WHO's proposals, AI and the their relationship to neurological disorders
- Current infrastructure for supporting the autism community
- Other similar initiatives to set up care communities/future housing for people with autism
Watch the episode on CHD.TV!
*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.
Resources
CHD Files FOIA Requests: Why Did Government Shut Down Studies on Cellphone Radiation and Cancer?
Is the WEF's Metaverse Just an 'Enforcement Regime' for Vaccination?
Pfizer's Misleading COVID Vaccine Claims 'Brought Discredit' on Big Pharma, UK Regulator Finds
'Low Credibility' Study Claims No Link Between Cellphone Use and Brain Tumors
'Heartbreaking': Pharma Eyes Exponential Growth in Multi-Billion Market for Autism Drugs
Vaccine Safety in 2023 - Where Have all the Critical Thinkers Gone?
HRSA | VICP Data and Statistics
Hiding Behind Genetics to Avoid Culpability for Environmental Causes of Autism
'Whole Thing Smacks of a Brave New World': New AI Tool Predicts Vaccine Hesitancy
Childhood Vaccine Schedule Led to 'Greatest Decline in Public Health in Human History'
Huge Untapped Demand in the $4+ Billion U.S. Autism Treatment Centers Market
J&J Uses 'Rare' Legal Challenge in Bid to Delay Lawsuits Alleging Tylenol Caused Autism
J.&J. to Pay $2.2 Billion in Risperdal Settlement (Published 2013)
